The 8th Annual Liquid Biopsy for Precision Oncology Summit is dedicated to the direction and rhetoric of the evolving liquid biopsy diagnostics.
The 8th Annual Liquid Biopsy for Precision Oncology Summit covers topics such as:
- Elevating Liquid Biopsy as a Biomarker- Driven Tool for Early Detection
- Staying Ahead of the Curve with the Rapidly Evolving Liquid Biopsy Landscape
- Utilizing Liquid Biopsy to Monitor Disease Progression & Relapse
- Defining Early Phase Clinical Considerations for Better Decision Making
- Expanding the Use of Liquid Biopsy to Monitor Tumor Resistance & Response to Therapy
- Enabling Successful Future of Liquid Biopsy-Driven Clinical Trials with Lessons Learned
- Harnessing IVDR Learnings for Accelerated Adoption & Commercialization of Liquid Biopsies
- Orchestrating Liquid Biopsy to be a Highly Efficacious Companion Diagnostic
- Overcoming Barriers to Liquid Biopsy Adoption with Today’s Regulatory Framework
- Paving the Path Towards Standardized Pre- Analytical Approaches in Liquid Biopsy
- Accelerating Commercialization & Reimbursement of Liquid Biopsy Tests towards Value-Based Healthcare System
- Effective Early Detection & Monitoring Strategies
The 8th Annual Liquid Biopsy for Precision Oncology Summit brings together attendees from biopharma, academia and Dx developers.
